GLRX3 and neoplasm: Comparative analysis revealed tumor-specific upregulation of GLRX3, IL1RN, and TNFRSF4 (p < 0.001), contrasting with downregulation of FCGRT, UBN2, and WNT5B in EC versus normal tissues (Figure 6C).